Pharmacovigilance Market Intelligence Report - Global Forecast to 2027

Pharmacovigilance Market Intelligence Report - Global Forecast to 2027

The Global Pharmacovigilance Market is projected to reach USD 15,458.60 million by 2027 from USD 6,669.16 million in 2021, at a CAGR 15.04% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Pharmacovigilance Market size was estimated at USD 2,509.54 million in 2021 and expected to reach USD 2,838.89 million in 2022, at a CAGR 14.57% to reach USD 5,677.22 million by 2027.
• The Asia-Pacific Pharmacovigilance Market size was estimated at USD 1,725.23 million in 2021 and expected to reach USD 2,017.39 million in 2022, at a CAGR 15.82% to reach USD 4,164.85 million by 2027.
• The Europe, Middle East & Africa Pharmacovigilance Market size was estimated at USD 2,434.37 million in 2021 and expected to reach USD 2,781.30 million in 2022, at a CAGR 14.95% to reach USD 5,616.52 million by 2027.

Market Segmentation & Coverage:

The report on pharmacovigilance identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the pharmacovigilance to forecast the revenues and analyze the trends in each of the following sub-markets:

Type:

• Contract Outsourcing
• In-house

Clinical Trial:

• Phase I
• Phase II
• Phase III
• Phase IV
• Pre-clinical

Method:

• Cohort Event Monitoring
• EHR Mining
• Intensified ADR Reporting
• Spontaneous Reporting
• Targeted Spontaneous Reporting

End User:

• Academic & Research Institutes
• Government Agencies
• Health Insurance Companies
• Hospitals & Care Providers
• Pharma & Biotech Companies

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• Accenture, PLC
• Bristol Myers Squibb
• C.H. Boehringer Sohn AG & Ko. KG
• Capgemini SE
• ClinChoice Inc.
• F. Hoffmann-La Roche AG
• GlaxoSmithKline PLC
• HCL Technologies Limited
• ICON PLC
• Infosys Limited
• International Business Machines Corporation
• IQVIA
• ITclinical
• Laboratory Corporation
• Linical Co., Ltd.
• Novartis International AG
• Oracle Corporation
• Parexel International
• Pfizer Inc.
• Quanticate International limited
• Sanofi S.A.
• Take Solutions Ltd.
• Tata Consultancy Services
• Wipro Limited